These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9803426)

  • 41. Fluoxetine in the treatment of premenstrual dysphoria.
    Su TP; Schmidt PJ; Danaceau MA; Tobin MB; Rosenstein DL; Murphy DL; Rubinow DR
    Neuropsychopharmacology; 1997 May; 16(5):346-56. PubMed ID: 9109106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral magnesium successfully relieves premenstrual mood changes.
    Facchinetti F; Borella P; Sances G; Fioroni L; Nappi RE; Genazzani AR
    Obstet Gynecol; 1991 Aug; 78(2):177-81. PubMed ID: 2067759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Menstrual-cycle effects on mood and perceptual-motor performance.
    Cockerill IM; Wormington JA; Nevill AM
    J Psychosom Res; 1994 Oct; 38(7):763-71. PubMed ID: 7877131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnesium (mg) retention and mood effects after intravenous mg infusion in premenstrual dysphoric disorder.
    Khine K; Rosenstein DL; Elin RJ; Niemela JE; Schmidt PJ; Rubinow DR
    Biol Psychiatry; 2006 Feb; 59(4):327-33. PubMed ID: 16197921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects.
    Hart RP; Colenda CC; Hamer RM
    Am J Psychiatry; 1991 Jan; 148(1):73-7. PubMed ID: 1984710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects.
    Allen D; Curran HV; Lader M
    Eur J Clin Pharmacol; 1991; 40(4):355-62. PubMed ID: 2050170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment.
    Sundblad C; Wikander I; Andersch B; Eriksson E
    Eur Neuropsychopharmacol; 1997 Aug; 7(3):201-6. PubMed ID: 9213079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of individual differences in alprazolam self-medication.
    Oswald LM; Roache JD; Rhoades HM
    Exp Clin Psychopharmacol; 1999 Nov; 7(4):379-90. PubMed ID: 10609973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Premenstrual Syndrome, Inflammatory Status, and Mood States in Soccer Players.
    Foster R; Vaisberg M; Bachi ALL; Dos Santos JMB; de Paula Vieira R; Luna-Junior LA; Araújo MP; Parmigiano TR; Borges F; Di-Bella ZIKJ
    Neuroimmunomodulation; 2019; 26(1):1-6. PubMed ID: 30654383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amnestic and anxiolytic effects of alprazolam in oral surgery patients.
    Coldwell SE; Milgrom P; Getz T; Ramsay DS
    J Oral Maxillofac Surg; 1997 Oct; 55(10):1061-70. PubMed ID: 9331228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose-response evaluation of the interaction between sertraline and alprazolam in vivo.
    Hassan PC; Sproule BA; Naranjo CA; Herrmann N
    J Clin Psychopharmacol; 2000 Apr; 20(2):150-8. PubMed ID: 10770452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Premenstrual mood and empathy after a single light therapy session.
    Aan Het Rot M; Miloserdov K; Buijze ALF; Meesters Y; Gordijn MCM
    Psychiatry Res; 2017 Oct; 256():212-218. PubMed ID: 28646784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myo-inositol has no beneficial effect on premenstrual dysphoric disorder.
    Nemets B; Talesnick B; Belmaker RH; Levine J
    World J Biol Psychiatry; 2002 Jul; 3(3):147-9. PubMed ID: 12478879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of placebo responses in medical treatment of premenstrual syndrome.
    Freeman EW; Rickels K
    Am J Psychiatry; 1999 Sep; 156(9):1403-8. PubMed ID: 10484952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Problems in the treatment of premenstrual syndrome.
    Robinson GE; Garfinkel PE
    Can J Psychiatry; 1990 Apr; 35(3):199-206. PubMed ID: 2187582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of alprazolam and buspirone in light and moderate female social drinkers.
    Evans SM; Levin FR
    Behav Pharmacol; 2002 Sep; 13(5-6):427-39. PubMed ID: 12394419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychotropic medications and other non-hormonal treatments for premenstrual disorders.
    Pearlstein T
    Menopause Int; 2012 Jun; 18(2):60-4. PubMed ID: 22611223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of premenstrual syndrome on ratings of anxiety in women with generalized anxiety disorder.
    McLeod DR; Hoehn-Saric R; Foster GV; Hipsley PA
    Acta Psychiatr Scand; 1993 Oct; 88(4):248-51. PubMed ID: 8256640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical inquiries. What medications are effective for treating symptoms of premenstrual syndrome (PMS)?
    Vleck JP; Safranek SM
    J Fam Pract; 2002 Oct; 51(10):894. PubMed ID: 12401165
    [No Abstract]   [Full Text] [Related]  

  • 60. Anticipatory anxiety in moderately to highly-anxious oral surgery patients as a screening model for anxiolytics: evaluation of alprazolam.
    Wolf DL; Desjardins PJ; Black PM; Francom SR; Mohanlal RW; Fleishaker JC
    J Clin Psychopharmacol; 2003 Feb; 23(1):51-7. PubMed ID: 12544376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.